Form 8-K - Current report:
SEC Accession No. 0001683168-17-001069
Filing Date
2017-05-02
Accepted
2017-05-02 08:07:33
Documents
4
Period of Report
2017-05-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT pharmabio_8k-050117.htm 8-K 21542
2 LETTER AGREEMENT pharmabio_8k-ex1001.htm EX-10.1 27793
3 PRESS RELEASE pharmabio_8k-ex9901.htm EX-99.1 13040
4 GRAPHIC image_001.jpg GRAPHIC 9094
  Complete submission text file 0001683168-17-001069.txt   76522
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 333-68008 | Film No.: 17802968
SIC: 2833 Medicinal Chemicals & Botanical Products